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MRIAbstract Objective: To analyze MR Spectroscopic ﬁndings and metabolite ratios in regions of
abnormal signal in children with leukodystrophies.
Methods: This prospective study was carried out on twenty-six children (17 males and 9 females);
median age, 36 months ± 54 inter-quartile range. The imaging protocol included axial T1 and T2-
weighted spin-echo and FLAIR images, and coronal and sagittal T2-weighted spin-echo images.
1H-MRSI was performed during the same session for all patients. Spectra were acquired from a
volume of interest in the affected white matter and intravoxel (NAA/Cr, Cho/Cr, and Cho/
NAA) ratios were calculated.
Results: Spectroscopic analysis revealed abnormal (NAA/Cr, Cho/Cr, and Cho/NAA) ratios.
Some were highly characteristic and speciﬁc as markedly elevated NAA resonance peak in cases
with Canavan’s disease and signiﬁcantly elevated lactate resonance peak in Leigh disease and
MELAS syndrome. In the majority of cases, elevated Cho/Cr, decreased NAA/Cr and elevated
Cho/NAA ratios were the dominant ﬁnding. One-way analysis of variance for the spectroscopic
metabolite ratios revealed statistical signiﬁcance (p< 0.0001).
Conclusion: Proton MR Spectroscopy complementary to conventional MRI proved to be a valu-
able tool to establish the diagnosis of leukodystrophies.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Leukodystrophies, are a wide spectrum of inherited neurode-
generative disorders that affect the integrity of myelin in the
brain and peripheral nerves. Most of these disorders areclassiﬁed into lysosomal storage diseases, peroxisomal disor-
ders, and diseases caused by mitochondrial dysfunction. Each
leukodystrophy has distinct clinical, biochemical, pathological,
and radiologic features (1).
MRI is highly sensitive in detecting white matter lesions.
However, MRI has a limited speciﬁcity as regards the patho-
logical conditions which result in white matter signal abnor-
malities, as all types of pathological disorders (e.g. edema,
gliosis, hypomyelination, demyelination and cystic white mat-
ter degeneration) result in prolongation of T1 and T2 relax-
ation times, leading to nonspeciﬁcally increased signal
Table 1 Type of leukodystrophy, number and percentage of
26 cases with white matter disease.
Leukodystrophy Number of cases Percent (%)
Krabbe’s disease 3 11.5
Canavan’s disease 4 15
Adrenoleukodystrophy 8 31
Leigh disease 6 23
MELAS syndrome 1 3.8
Metachromatic leukodystrophy 3 11.5
Pelizaeus–Meurzbacher’s 1 3.8
Total 26 100
1092 E.M. Abdelsalam et al.intensity on T2 weighted MR images and decreased signal
intensity on T1 weighted MR images (2).
Proton MR Spectroscopy (1H-MRS) is one of the quan-
titative MR techniques which may provide more insight into
underlying white matter pathological changes (3,4). Magnetic
resonance spectroscopy (MRS) is generally known as the
analytical method in chemistry which identiﬁes molecules
and determines their biophysical characteristics. MRS allows
detection of relatively small molecules in concentrations of
0.5–10 m-Moles, within the cells or in the extra-cellular
spaces (5). 1H MRS and routine MRI share the same
radiofrequency range, so, no expensive scanner upgrade is
needed; hence, it provides a cost-effective additional diagnos-
tic modality (6).
1H-MRS detects 3 main metabolite peaks: N-acetylaspartate
(NAA), marker of the neuronal integrity; choline (Cho), mem-
brane marker; and creatine (Cr), peak represents the energy
reservoirs. Other peaks detected at short TE include myo-
inositol (mI), marker of glial function and lactate (lac) marker
of anaerobic glycolysis (7,8). The detection of lactate resonance
peak in brain parenchyma indicates cerebral lactic acidosis with
reliability higher than blood and CSF lactate levels (9). Absolute
and relative concentrations of these metabolites vary with age.
In neonates, Cho and mI are the prominent peaks, whereas
NAA is low; by 4 months, NAA becomes more prominent,
whereas Cho and mI decrease; an adult appearance is reached
by 6 months of age (8).
Absolute quantiﬁcation of metabolites is not routinely
obtained; instead, relative concentrations to creatine (metabo-
lite ratios) are measured, based on the fact that creatine (Cr)
remains stable throughout life, denoting the stability of energy
storage in the brain under normal conditions. Therefore, Cr is
conﬁdently used as a control value in relation to other metabo-
lites (10).
The aim of this study was to analyze MR Spectroscopic
ﬁndings and metabolite ratios in regions of abnormal signal
intensity seen in children with leukodystrophies.
2. Patients and methods
This prospective study was conducted in the period between
January 2012 and March 2014. Cases were referred from
University Children Hospital where a pediatric neurology spe-
cialist performed the clinical and neurologic examinations.
Twenty-six children (17 males and 9 females) were included;
median age, 36 months ± 54 inter-quartile range. MRI imag-
ing was done after parents’ informed consent waived.
Conventional MR Imaging and MR Spectroscopic Imag-
ing: all examinations were performed at 1.5T (Acheiva; Philips
Medical Systems, Best, Netherlands). The imaging protocol
included axial T1 and T2-weighted spin-echo and FLAIR
images, and coronal and sagittal T2-weighted spin-echo
images. 1H-MRS was performed during the same session for
all patients with a single-section multivoxel 2D chemical shift
spectroscopy sequence (short TE = 35 ms and intermediate
TE = 135 ms) with a nominal planar resolution of
10  10 mm (FOV= 160  160 mm2, matrix = 16  16) and
15-mm section thickness. Water suppression was performed
with a selective inversion pulse after automatic shimming
and gradient tuning. Spectra were acquired from a volume of
interest in the affected white matter (4–6 mL).1H-MRS raw data were transferred to the Workstation
(Extended MR workspace 2.6.3.4; CE Netherland). After base-
line correction, peak areas of choline (Cho), creatine (Cr), and
N-acetylaspartate (NAA) were estimated by numeric integra-
tion. White matter intravoxel (NAA/Cr, Cho/Cr, and Cho/
NAA) ratios were calculated. Spectra in the cortical gray mat-
ter and CSF were spared in all types of leukoencephalopathies
included in this study.
Final diagnosis was established by the integration of clini-
cal and radiologic ﬁndings together with laboratory metabolic
analysis and study of lysosomal enzyme deﬁciency.
Statistical analysis was performed by using the program
Statistical Package for the Social Sciences (SPSS) Version
20.0 for Windows. Analysis of variance for the spectroscopic
ratio metabolite measures was performed. Tukey Honest Sig-
niﬁcant Difference post hoc test was used to estimate statistical
signiﬁcance.
3. Results
Conventional and spectroscopic MRI studies were conducted
for all 26 cases with variable white matter diseases (Table 1).
Conventional MRI study revealed leukodystrophy in white
matter of the 26 cases of the study, in the form of bilateral
symmetrical diffuse abnormal low SI on T1 and high SI on
T2WIs and FLAIR images (Fig. 1). Bilateral swelling and
edema of the basal ganglia and thalami was reported in cases
with mitochondrial enzyme deﬁciency (Fig. 2) and krabbe dis-
ease as well as brain stem edema as reported in Pelizaeus–
Meurzbacher’s disease (Fig. 3).
Spectroscopic analysis revealed abnormal (NAA/Cr, Cho/
Cr, and Cho/NAA) ratios. Some were highly characteristic
and speciﬁc as markedly elevated NAA resonance peak in
cases with Canavan’s disease (Fig. 4). Others revealed signiﬁ-
cantly elevated lactate resonance peak e.g. Leigh disease
(Fig. 2) and MELAS syndrome. In the majority of cases (23
out of 26, 88.5%), elevated Cho/Cr ratio, decreased NAA/Cr
ratio and elevated Cho/NAA were the dominant ﬁnding
(Figs. 1 and 5).
One-way analysis of variance for the presented 3 spectro-
scopic metabolite ratios revealed statistical signiﬁcance
p< 0.0001 (Table 2). Further statistical analysis was done to
discriminate whether signiﬁcant statistical difference existed
between particular metabolic rations. Signiﬁcant statistical dif-
ference was found between Cho/Cr and Cho/NAA ratios,
Fig. 1 Adrenoleukodystrophy in a 7 years old boy: dysmyelination in the form of bilateral abnormal low SI on T1WIs and high SI on T2
and FLAIR images seen in the deep periventricular white matter, with posterior predilection and involving the splenium of corpus
callosum. Subcorical U ﬁbers are spared. MRS (intermediate TE = 135 ms): markedly elevated Cho/Cr ratio and decreased NAA/Cr
ratio in the area of active dysmyelination: Cho/Cr = 1.4.
Fig. 2 Leigh disease in a 2 years old girl: bilateral abnormal high SI on T2WIs is seen in basal ganglionic regions. MRS (intermediate
TE = 135 ms): Cho/Cr ratio = 1.1, NAA/Cr = 0.7, Cho/NAA= 1.2. Markedly elevated lactate (lac) peak is clearly demonstrated.
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Fig. 3 Pelizaeus–Merzbacher’s disease in a 10 months old boy with microcephaly: bilateral symmetrical leukodystrophy. Abnormal high
SI is noted in pons. (C) MRS: (TE = 135 ms): Cho/Cr, NAA/Cr and Cho/NAA ratios are within the normal range. Inverted lactate
doublet peak is seen. Signiﬁcantly elevated mI peak is seen although intermediate TE is used.
1094 E.M. Abdelsalam et al.through Post hoc test for analysis of variance by disease
(Table 3).
4. Discussion
MR Spectroscopy can be used to discriminate between differ-
ent types of white matter disorders and to classify white matter
lesions of unknown origin with respect to underlying patholog-
ical conditions (11).
A small number of leukodystrophies is associated with
speciﬁc characteristic ﬁndings on 1H-MRS as a result of alter-
ations of normal resonance peaks or appearance of abnormal
metabolites that are speciﬁcally associated with a particular
metabolic disorder (12). Among those, Canavan’s disease;
diagnosis of which is established by elevated NAA signal in
conjunction with absence of myelination and progressive
increase in head circumference (3). In our study, this was
demonstrated in four cases diagnosed as Canavan’s disease
where NAA resonance peak was markedly elevated and
NAA/Cr ratio was signiﬁcantly high (Fig. 4). This is attributed
to the deﬁciency of N-acetylaspartylase, which results inaccumulation of N-acetylaspartic acid in the urine, plasma,
and brain (1).
Similarly, elevated lactate peak was a consistent ﬁnding in
all cases with Leigh disease (Fig. 2) as well as the case with
MELAS syndrome, which presented with lower limb myopa-
thy and lactic acidosis together with leukodystrophy. Elevated
Cho peak and reduced NAA were also noted. These ﬁndings
are in agreement with previous studies (13,14). Increased lac-
tate is indicative of anaerobic glycolysis. This can be due
to the impairment of oxidative phosphorylation occurring
in mitochondrial disorders (9). Consequently, in cases of
mitochondrial disorders, 1H-MRS plays an important role in
the diagnostic workup because it allows the noninvasive deter-
mination of cerebral lactate, which may be increased in the
absence of peripheral lactic academia (15).
Adrenoleukodystrophy (ALD) is a peroxisomal disorder
(an inborn error of metabolism which results from the deﬁ-
ciency of peroxisomal enzyme) affecting the central nervous
system, adrenal cortex, and testicles. The most common
presentation is in childhood, with clinical onset between 4
and 8 years of age. It presents with behavioral and school
Fig. 4 Canavan’s disease in a 9 months old girl. Extensive dysmyelination in the form of bilateral symmetrical abnormal low SI on
T1WIs and high SI on T2WIs throughout the white matter, resulting in cortical thinning. Involvement of the subcortical U ﬁbers is also
noted. MRS (intermediate TE = 135 ms): strikingly elevated NAA peak, while other metabolite peaks are decreased.
Proton MR Spectroscopy in leukodystrophies 1095performance deterioration and progressive cognitive impair-
ment (16). In our study, the typical clinical presentation and
radiologic appearance on conventional MRI (predilection to
posterior white matter) (Fig. 1) led to the diagnosis of ALD.
However, spectroscopic study did not reveal any pathog-
nomonic resonance peak as the previous cases. Yet, abnormal
increase of Cho/Cr and Cho/NAA ratios with the decrease of
NAA/Cr ratio was reported in our study as well as others
(17,18).
Conventional MRI study for metachromatic leukodystro-
phy (MLD) is characterized by bilateral symmetrical abnormal
high SI on T2 and FLAIR images in the deep periventricular
white matter, with sparing of the subcortical U ﬁbers and
peripheral ‘‘tigeroid” or ‘‘leopard pattern” of dysmyelination
(Fig. 5). On MRS, increased Cho/Cr, Cho/NAA ratios and
decreased NAA/Cr ratio were reported as well as elevated
myoinositol (mI) peak which is attributed to glial abnormali-
ties and membrane instability (3,12,17).
Cerebellar white matter leukodystrophy and brain stem
abnormal signal intensity were demonstrated in Krabbe’s dis-
ease and Pelizaeus–Meurzbacher’s disease. On MRS Krabbe’s
disease demonstrated the same nonspeciﬁc ﬁndings including
reduced NAA resonance peak and elevated Cho resonancepeak. Meanwhile, in Pelizaeus–Meurzbacher’s disease metabo-
lite resonance peaks were within the normal range (Fig. 3C).
Some authors reported that Pelizaeus–Meurzbacher’s disease
demonstrated metabolite resonance peaks and ratios similar
to the normal age matched control group (19,20). Others
reported elevated Cho and reduced NAA resonance peaks
(3,20).
Based on the results of our study we can deduce that ele-
vated Cho and reduced NAA resonance peaks with subsequent
elevation of Cho/Cr and Cho/NAA and reduced NAA/Cr
ratios are a consistent ﬁnding in leukodystrophies. Conse-
quently, elevation of Cho associated with NAA loss is the hall-
mark of leukoencephalopathies with demyelination. High Cho
occurs as a result of a combination of several factors: presence
of inﬂammatory cells in the lesion, accumulation of myelin
breakdown products such as glycerophosphocholine and phos-
phocholine and increased membrane turnover (20). In the fully
demyelinated, burnt-out zone, NAA is severely decreased due
to neuronal degeneration (21).
Moreover, some leukodystrophies display pathognomonic
ﬁndings on spectroscopic analysis as Canavan’s and mitochon-
drial diseases. Other studies reported the reduced Creatine and
elevated Myoinostol resonance peaks as speciﬁc ﬁndings in
Fig. 5 Metachromatic leukodystrophy in a 4 years old girl (A) T2-weighted MR images show numerous linear tubular structures with
low signal intensity in a radiating (‘‘tigeroid”) pattern within the demyelinated deep white matter. MRS (short TE = 35 ms): Cho/
Cr = 0.8, NAA/Cr = 0.9, Cho/NAA= 1.2. High mI peak is also noted.
Table 2 One-way analysis of variance demonstrates signiﬁ-
cant statistical difference in the values of the three metabolite
ratios.
ANOVA
Sum of
squares
df Mean
square
F Sig.
Ratios
Between
groups
5.047 2 2.524 9.117 .000
Within groups 20.760 75 .277
Total 25.807 77
Table 3 Post hoc tests for analysis of variance by disease
revealed signiﬁcant statistical difference for Cho/NAA and
Cho/Cr ratios.
Multiple comparisons
Dependent variable: ratios Tukey HSD
(I)
Group
(J)
Group
Mean
diﬀerence
(I–J)
Std.
error
Sig. 95% Conﬁdence
interval
Lower
bound
Upper
bound
Cho/
Cr
NAA/
Cr
.31538 .14688 .087 .0359 .6667
Cho/
NAA
.62031* .14835 .000 .2655 .9751
NAA/
Cr
Cho/
Cr
.31538 .14688 .087 .6667 .0359
Cho/
NAA
.30492 .14835 .106 .0499 .6597
Cho/
NAA
Cho/
Cr
.62031* .14835 .000 .9751 .2655
NAA/
Cr
.30492 .14835 .106 .6597 .0499
* The mean difference is signiﬁcant at the 0.05 level.
1096 E.M. Abdelsalam et al.creatine enzyme deﬁciency and nonketotic hyperglycemia,
respectively (22,10). Decreased number of patients is a limita-
tion of our study. This is because the disease is rare; also
patients were excluded when deﬁnitive laboratory diagnosis
couldn’t be obtained or because of early death with lack of
postmortem autopsy.
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Proton MR Spectroscopy complementary to conventional
MRI proved to be a valuable tool to establish the diagnosis
of leukodystrophies. Although elevated Cho resonance peak
is a nonspeciﬁc ﬁnding, it is considered a hallmark of the meta-
bolic changes that accompany the active demyelination.
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